All Stories

  1. Visually Guided Laser Ablation for Atrial Fibrillation: First experience in Greece
  2. Arteriosclerosis and arterial remodeling; different mechanisms in young adults
  3. Usefulness of a Structured Adult Education Program in Modifying Markers of Cardiovascular Risk After Acute Myocardial Infarction
  4. “TAVI: Valve in valve. A new field for structuralists? Literature review”
  5. Are Drugs Always the Proper Solution to Therapeutic Dilemmas? Non-drug Approaches to the Post-traumatic Stress “Waking Corpse” Syndrome
  6. The Role of Calcium Handling Mechanisms in Reperfusion Injury
  7. The Role of Colchicine in Treating Postoperative and Post–Catheter Ablation Atrial Fibrillation
  8. Colchicum Genus in the Writings of Ancient Greek and Byzantine Physicians
  9. Invasive treatment in peripheral artery disease
  10. Ambulatory Pulse Wave Velocity Monitoring
  11. Permanent pacemaker implantation in octogenarians with unexplained syncope and positive electrophysiologic testing
  12. Remote Ischemic Conditioning and Renal Protection
  13. Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
  14. Peri-procedural Anticoagulation in Catheter Ablation for Atrial Fibrillation: A Review
  15. Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI
  16. Genetics in the Clinical Decision of Antiplatelet Treatment
  17. Editorial: Antiplatelet and Anticoagulation Treatment in Special Populations
  18. In Vivo Assessment of Atherosclerotic Plaque Neovascularization by Contrast-Enhanced Ultrasound: An Unsolved Mystery?
  19. Impact of balloon aortic valvuloplasty on transcatheter aortic valve implantation with self-expandable valve
  20. Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence
  21. Correlation of CoreValve implantation ‘true cover index’ with short and mid-term aortic regurgitation: A novel index
  22. Dual or Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation? A Systematic Review and Meta-Analysis
  23. Assessment of the vulnerable carotid atherosclerotic plaque using contrast-enhanced ultrasonography
  24. Circulating Erythrocyte Microparticles and the Biochemical Extent of Myocardial Injury in ST Elevation Myocardial Infarction
  25. Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals
  26. Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
  27. Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
  28. Antiplatelet Therapy in TAVI: Current Clinical Practice and Recommendations
  29. Jean-Baptiste de Senac's (1693-1770) Important Work on Cardiology and Valvular Disorders
  30. A Preliminary Study on In-Vivo 3-D Imaging of Bioprosthetic Aortic Valve Deformation
  31. Central Blood Pressure Measurement
  32. Essential hypertension in the pathogenesis of age-related macular degeneration
  33. Novel Inflammatory Indices in Aortic Disease
  34. An alternative method of percutaneous mitral valvuloplasty. Matching electrophysiology with interventional cardiology techniques
  35. Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience
  36. Percutaneous Closure of a Large Ascending Aorta Pseudoaneurysm Due to Mediastinitis Using an Amplatzer Occluder Device
  37. Vascular Sealing Implications in Transfemoral Transcatheter Aortic Valve Implantation
  38. Residual platelet reactivity after clopidogrel loading in ST-elevation myocardial infarction patients undergoing a delayed catheterization. Impact on long term clinical events
  39. Implicaciones del sellado vascular en el implante percutáneo transfemoral de válvula aórtica
  40. Percutaneous paravalvular leak closure after TAVI: A demanding approach
  41. Cardiac echo-lab productivity in times of economic austerity
  42. Effect of supine versus sitting position on noninvasive assessment of aortic pressure waveform: a randomized cross-over study
  43. Impact of inflammatory process on left ventricular recovery after Transcatheter Aortic Valve Implantation
  44. Non-invasive 24hour ambulatory monitoring of aortic wave reflection and arterial stiffness by a novel oscillometric device: The first feasibility and reproducibility study
  45. Predictive Factors of Vascular Complications after Transcatheter Aortic Valve Implantation in Patients Treated with a Default Percutaneous Strategy
  46. Troponin levels after TAVI are related to the development of distinct electrocardiographic changes
  47. MicroRNAs in Aortic Disease
  48. Quantitative analysis of carotid plaque vasa vasorum by CEUS and correlation with histology after endarterectomy
  49. Inferior epigastric artery as a landmark for transfemoral TAVI. Optimizing vascular access?
  50. Assessment of Left Atrial Function after Percutaneous Closure of Patent Foramen Ovale
  51. CoreValve deployment during cardiopulmonary resuscitation without angiographic injections guidance
  52. Feasibility and Reproducibility of Noninvasive 24-h Ambulatory Aortic Blood Pressure Monitoring With a Brachial Cuff-Based Oscillometric Device
  53. Effect of transcatheter aortic valve implantation on the ascending aorta’s elasticity
  54. Biomarkers as a Guide of Medical Treatment in Cardiovascular Diseases
  55. Residual Platelet Reactivity After Clopidogrel Loading in Patients With ST-Elevation Myocardial Infarction Undergoing an Unexpectedly Delayed Primary Percutaneous Coronary Intervention
  56. Trans-catheter aortic-valve implantation by the subclavian approach complicated with vessel dissection and transient left-arm paralysis
  57. “Bail out” procedures for malpositioning of aortic valve prosthesis (CoreValve)
  58. A 53-Year-Old Woman With Recurrent Transient Ischemic Attacks
  59. Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access
  60. CoreValve Aortic Bioprosthesis